Nitric oxide is a potent inhibitor of the cbb3-type heme-copper oxidases  by Arjona, Davinia et al.
FEBS Letters 589 (2015) 1214–1218journal homepage: www.FEBSLetters .orgNitric oxide is a potent inhibitor of the cbb3-type heme-copper oxidaseshttp://dx.doi.org/10.1016/j.febslet.2015.03.033
0014-5793/ 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Author contributions: P.Ä. and M.W. designed the study, D.A. performed the
experiments, D.A. and P.Ä. analyzed data, P.Ä. wrote the manuscript, D.A., P.Ä.
and M.W. revised the manuscript.
⇑ Corresponding author. Fax: +46 8 153679.
E-mail address: piaa@dbb.su.se (P. Ädelroth).Davinia Arjona a, Mårten Wikströmb, Pia Ädelroth a,⇑
aDepartment of Biochemistry and Biophysics, The Arrhenius Laboratories for Natural Sciences, Stockholm University, SE-106 91 Stockholm, Sweden
bHelsinki Bioenergetics Group, Institute of Biotechnology, University of Helsinki, FI-00014 Helsinki, Finlanda r t i c l e i n f o
Article history:
Received 23 February 2015
Revised 19 March 2015
Accepted 26 March 2015
Available online 8 April 2015






Nitritea b s t r a c t
C-type heme-copper oxidases terminate the respiratory chain in many pathogenic bacteria, and will
encounter elevated concentrations of NO produced by the immune defense of the host. Thus, a
decreased sensitivity to NO in C-type oxidases would increase the survival of these pathogens.
Here we have compared the inhibitory effect of NO in C-type oxidases to that in the mitochondrial
A-type. We show that O2-reduction in both the Rhodobacter sphaeroides and Vibrio cholerae C-type
oxidases is strongly and reversibly inhibited by submicromolar NO, with an inhibition pattern simi-
lar to the A-type. Thus, NO tolerance in pathogens with a C-type terminal oxidase has to rely mainly
on other mechanisms.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Heme-copper oxidases (HCuOs) are integral membrane proteins
that catalyze reduction of oxygen to water as the ﬁnal reaction of
the respiratory chain, and conserve the energy thereby released
by contributing to the proton electrochemical gradient. All
HCuOs have a homologous catalytic subunit with twelve trans-
membrane helices containing six invariant histidines which ligate
three cofactors; a high-spin heme and a copper ion (CuB) in the cat-
alytic site, and an additional low-spin heme. The HCuO superfamily
is classiﬁed into three major subfamilies denoted A-, B-, and C-type
[1,2]; in addition, the bacterial NO-reductases (NOR) belong to the
same family where they form their own subfamily.
In the mitochondrial, or A-type HCuOs, electrons ﬂow from the
donor cytochrome (cyt.). c to a dinuclear CuA-site in subunit (SU) II,
and from there into the low-spin heme a in SU I before reaching the
binuclear heme a3-CuB active site where O2 is bound and reduced.
Protons are transferred through two deﬁned pathways (see [3] for
a recent review on proton pathways in the HCuO family) up to the
catalytic site, the D- and the K-pathway. Both B- and C-type HCuOsdiffer from the A-type in that they presumably use only a K-path-
way analogue for proton transfer [2,4–6].
The C (cbb3) family of oxidases are found mainly in bacteria, and
are often expressed under semi-anaerobic conditions as they show
a low Km for O2 [7]. They are the O2-reducing HCuOs evolutionarily
closest to the NORs and most distant from the A-type [1,8]. The C-
type enzymes also have the highest NO-reduction activity, except-
ing the true NORs [9,10]. In C-type HCuOs, the catalytic subunit
CcoN contains the high-spin heme b3-CuB catalytic site and a
low-spin heme b. C-type HCuOs further typically consist of two
membrane-anchored c-cytochromes; CcoO with one c-type heme,
and CcoP with two c-type hemes, where electrons are presumed
to enter from the donor cyt. c. The C-type HCuO from
Pseudomonas (P.) stutzeri was recently structurally deﬁned at
atomic resolution [11].
C-type oxidases are often found in human pathogens since the
lower Km for O2 enables colonization of microaerophilic habitats.
In some pathogens, such as Helicobacter (H.) pylori and Neisseria
(N.) meningitidis, the C-type HCuO is the only terminal oxidase,
and therefore a potential drug target [12]. Pathogenic bacteria
are likely to encounter elevated NO concentrations as NO is pro-
duced by macrophages in the immune defense of the host, and
an increased NO tolerance of C-type oxidases would beneﬁt the
pathogens that harbor it.
For the mitochondrial A-type oxidase there is a large body of
literature concerning inhibition by NO, which is a potent reversible
inhibitor of respiration (for a recent review, see [13]). In the
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IC50s in the nM range [14]), and to several different intermediates
in a range of different modes (see e.g. [15,16]).
In this study, we have compared the sensitivity to NO inhibition
of the C-type HCuOs from both Vibrio (V.) cholerae and Rhodobacter
(R.) sphaeroides to that of the A-type HCuO from R. sphaeroides. Our
aim was to investigate whether the C-type HCuOs exhibit general
insensitivity to NO inhibition. Furthermore, we wanted to learn if
the NO-reduction activity in C-type HCuOs inﬂuenced the inhibi-
tion behavior. Our results show that O2-reduction in C-type
oxidases is strongly and reversibly inhibited by NO with the IC50
in the nanomolar range, similar to A-type HCuOs. In the two
HCuOs from R. sphaeroides, the IC50 is higher for the C-type than
for the A-type HCuO, but the overall behavior is very similar. In
the V. cholerae cbb3, however, the IC50 is very similar to that found
in R. sphaeroides aa3. These differences in the details of the inhibi-
tion will be discussed, but it is clear that mechanisms other than
general NO insensitivity for C-type oxidases must be operating in
pathogens with an increased NO tolerance.
2. Materials and methods
2.1. Protein puriﬁcation
The R. sphaeroides Dcbb3 strain carrying the plasmid
pUI2803NHIS [17] was grown, and the cbb3 wildtype puriﬁed as
in [5].
The V. choleraeDcbb3 strain with plasmids for the polyhistidine-
tagged cbb3 protein were grown and the cbb3 wildtype was puriﬁed
essentially as in [18] but with the following modiﬁcations: the elu-
tion from the Ni2+-agarose resin was performed using a gradient of
5–200 mM imidazole, and the major V. cholerae cbb3 peak that
elutes around 100 mM imidazole was collected. Imidazole was
removed by repeated dilutions and concentrations in 20 mM Tris,
pH 8.0, 100 mMNaCl, 0.05% b-D-dodecyl maltoside (DDM), and
the protein ﬂash frozen in liquid nitrogen and stored at 80 C.
2.2. NO stock solutions and other reagents
The NO solution was prepared by bubbling NO (100% or 5% NO
(in N2)) gas into water made anaerobic by bubbling with N2 as in
[19]. Sodium nitrite (Sigma) stock solution was prepared in a con-
centration of 1–10 mM. Equine cytochrome (cyt.) c, and bovine
hemoglobin (Hb) were from Sigma.
2.3. Steady-state activity measurements and data handling
The steady-state O2 reduction activity of the different HCuOs
was measured using a Clark-type electrode (Hansatech). The reac-
tion chamber was ﬁlled (total of 1 mL) with 100 mM HEPES-KOH,
pH 7.3, 50 mM KCl, 0.07% DDM, 10 mM ascorbate, 0.2 mM
N,N,N0,N0-tetramethyl-p-phenylenediamine (TMPD), and 18 lM
cyt. c. For measurements with the cbb3 from V. cholerae, a
100 mM HEPES-NaOH at pH 7.3, 100 mM NaCl, 0.07% DDM buffer
was used. Oxygen consumption was initiated by the addition of
the enzymes, and different amounts of NO were added when the
oxygen level had decreased to either 200 or 60 lM. The starting
activity varied somewhat between preparations of the HCuOs,
but was typically 700 e/s for Rs aa3, 350 e/s for Rs cbb3 and
150 e/s for Vc cbb3.
Instead of reporting IC50 as the NO concentration that gives 50%
inhibition, we ﬁtted the inhibitory effect of increasing amounts of
added NO on the turnover activity of aa3/cbb3 as in [20], to Eq. (1)
using Sigmaplot (Systat Software). Note that this is not a ﬁt of
dissociation constants for the enzyme-NO complex, as it acts as acompetitive inhibitor (at least partly), but rather a way of reporting
IC50s using all available data. Note that because of very tight
NO-binding (especially at lower O2), the [NO] in Eq. (1) refers to
the unbound [NO] in solution taking the enzyme concentration
into account.
Vobs ¼ V01þ ½NO=IC50 ð1Þ3. Results
3.1. NO inhibition of catalytic activity in C-type oxidases
NO inhibits catalytic O2 reduction in C-type oxidases strongly
and reversibly, as shown in Fig. 1. When 1 lM NO is added to
both A (Fig. 1A) and C-type oxidases (Fig. 1B and C), catalytic turn-
over is completely inhibited, but activity is regained after a certain
amount of time, presumably because NO is slowly degraded in the
presence of O2, indicating that recovery occurs as NO is released
from the active site. If hemoglobin (Hb) is added after NO, the
recovery speeds up, as observed previously in A-type oxidases
[13], since Hb can compete with the HCuOs for NO binding. We
note that there is no signiﬁcant difference in the time it takes to
regain 50% activity between the R. sphaeroides A- and C-type oxi-
dase (Table 1), which means that the NO-reduction activity exhib-
ited by the C-, but not the A-type oxidase [9,10], does not
signiﬁcantly inﬂuence this time (see Section 4). The ﬁnal recovered
activity after Hb addition is slightly larger for the cbb3s (90% of the
original value, see Table 1) than for the Rs aa3 (80%), which might
be related to the sensitivity to NO2 (see below).
When the NO solutions are prepared, especially from only 5%
NO, there is a risk that some NO is converted to nitrite by reacting
with small amounts of residual O2. Therefore we also tested the
inhibitory effect of nitrite on turnover of the A- and C-type
HCuOs. The results show that there is inhibition by nitrite, but at
higher concentrations (at least several lM for R. sphaeroides aa3
and cbb3 and even more for V. cholerae cbb3) than with NO and with
a different inhibition pattern (data not shown). Interestingly, in the
R. sphaeroides aa3, when 10 lM NO2 is added at 60 lM O2, inhibi-
tion recovers after a certain time, much like when adding NO, pos-
sibly indicating that some NO2 is converted to NO, as previously
suggested for the mitochondrial aa3 [21]. Basically, however, NO2
inhibition occurs at high enough concentrations that we assume
it does not signiﬁcantly inﬂuence our NO inhibition data.
3.2. Determination of the IC50 for NO inhibition in C-type oxidases
We titrated the effect on activity as a function of added NO in
the three HCuOs used in Fig. 1, as exempliﬁed by the data shown
for R. sphaeroides cbb3 in Fig. 2. Plots of the O2-reduction rate
immediately after NO addition as a function of added NO in the
two HCuOs (aa3 and cbb3) from R. sphaeroides at both higher
(200 lM) and lower (60 lM) O2 are shown in Fig. 3, and ﬁts
of the data to Eq. (1) are shown as solid lines. The obtained IC50 val-
ues are 60 nM and 280 nM NO at 200 lM O2 (A), and 6 nM NO
and 60 nM NO at 60 lM O2 (B) for the R. sphaeroides aa3 and
cbb3, respectively. Fig. 4 shows the comparison between R. sphaer-
oides and V. cholerae cbb3 giving IC50s for the Vc cbb3 of 30 nM NO
(A; 200 lM O2) (A) and 4 nM NO (B; 60 lM O2).
It should be noted that the conditions of the V. cholerae cbb3
assay are different (as horse heart cyt. c is not a good substrate,
see [22]) from the conditions in which the two R. sphaeroides
HCuOs are assayed; hence, the IC50 values might not be as easily
compared. If the rate of electron input into the Rs HCuOs is
increased by increasing the amount of cyt. c in the assay, the initial
turnover rate increases somewhat and the sensitivity to NO
AB
C
Fig. 1. Effect of NO on O2-reduction by the C-type versus A-type HCuO from R.
sphaeroides. O2-consumption is initiated by the addition of the HCuOs, 10 nM each
for the R. sphaeroides (Rs) aa3 (A), Rs cbb3 (B) and V. cholerae (Vc) cbb3. NO at ﬁnal
concentration of 1 lM and hemoglobin (Hb, 2 lM) was added as indicated by
arrows. Experimental conditions (A and B): 100 mM HEPES-KOH pH 7.3, 50 mM
KCl, 0.07% DDM, 10 mM ascorbate, 0.2 mM TMPD, and 18 lM horse heart cyt. c. For
V. cholerae, the buffer contained 100 mM HEPES-NaOH pH 7.3, 100 mM NaCl and
0.07% DDM. T = 297 K.
Table 1
Details of NO inhibition in R. sphaeroides aa3, R. sphaeroides cbb3 and V. cholerae cbb3 as sho
absence of NO.
HCuO Rate after NO addition (%) Rate after recovery (%)
Rs aa3 0 70
Rs cbb3 0 63
Vc cbb3 0 72
1216 D. Arjona et al. / FEBS Letters 589 (2015) 1214–1218decreases (data not shown), as would be expected if the inhibition
is partly due to NO binding to the oxidized active site, the steady-
state concentration of which decreases with higher reduction rates.
When reduction rates are increased in the assay with V. cholerae
cbb3 (by increasing the ascorbate/TMPD concentrations), the initial
turnover rate also increases but the sensitivity to NO is unchanged
(data not shown), indicating a possible difference in the mecha-
nism of inhibition. A full analysis of this behavior is beyond the
scope of this work, but it is clear that the comparison of the IC50s
between the two different cbb3s is not straight-forward.
4. Discussion
In this study, our aim was to study the effect of nitric oxide on
oxygen reduction by puriﬁed C-type HCuOs, as this has to our
knowledge not been reported on before. We wanted to investigate
if there are signiﬁcant differences in C-type compared to the
mitochondrial A-type HCuOs that might give pathogens that
express a C-type oxidase an advantage in combatting the immune
defense of the host, where NO is produced by macrophages. Our
results show that cbb3s are inhibited by NO in a manner very simi-
lar to aa3, i.e. strongly and reversibly; 1 lM of NO was enough to
completely block O2-reduction activity in both V. cholerae and R.
sphaeroides cbb3 (see Fig. 1). This is interesting since at least one
(other) pathogen, H. pylori, which causes gastric ulcers, would
encounter even higher NO concentrations ([NO] in gastric juice is
around 5 lM [23]) and H. pylori cell suspensions were shown to
be resistant to NO [24]. Park et al. found that respiration in intact
H. pylori cells, in which the only terminal oxidase is of the cbb3-
type, was only slightly inhibited by micromolar NO [24], whereas
the same NO concentrations caused complete inhibition in intact
Escherichia coli cells, which harbor both an A-type (bo3) HCuO
and a bd-type oxidase. It should be noted that mechanisms, other
than a low sensitivity of its C-type HCuO, for the resistance of H.
pylori to NO have been suggested, e.g. that it is conferred by spe-
cialized NO-degrading enzymes [25].
The C-type HCuOs that we used; from R. sphaeroides and V. cho-
lerae, both proteobacteria, share 55% sequence identity in the cat-
alytic CcoN subunit. Further, they both share about 40% sequence
identity to the CcoN of H. pylori, and the V. cholerae CcoN shares
70% identity with the CcoN in another pathogen; N. meningitidis,
in which the cbb3 oxidase is also the only terminal oxidase. Of
course, in order to fully understand NO inhibition in the C-type oxi-
dases from H. pylori or N. meningitidis, they will have to be studied
speciﬁcally, studies that are underway in our laboratory.
Our results further show that similar to in A-type HCuOs, after
NO addition, the activity is regained after a time interval, due to
degradation of NO, and the release of inhibition is sped up when
hemoglobin is added, as it acts as a ‘scavenger’ of NO (see Fig. 1
and Table 1). We also note that there is no clear difference in the
time it takes from the addition of saturating (i.e. giving full inhibi-
tion) amounts of NO until half the original activity is regained
(Table 1) between the Rs cbb3 and aa3. This result indicates that
although the cbb3, in contrast to the aa3, shows NO-reductionwn in Fig. 1. Unless stated otherwise, the rates refer to the % of the initial rate in the
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tor to the various ways in which the added NO is degraded in the
presence of O2.
The obtained IC50s vary somewhat between reaction buffers
and since the V. cholerae enzyme is assayed without cyt. c as the
electron donor, the most straight-forward comparison should be
between the R. sphaeroides aa3 and cbb3, from the same bacteria
and assayed using the same conditions. Here, there is a lower afﬁn-
ity for NO in the cbb3 (IC50 is 5–10 times higher, see Fig. 3), but both
oxidases exhibit IC50s in the nanomolar range. The V. cholerae cbb3
on the other hand shows IC50s for NO very similar to the R. sphaer-
oides aa3 (see Fig. 4). At such tight binding, knowing the exact
amount of added enzyme also becomes important and theFig. 2. Titration of activity at different NO concentrations in R. sphaeroides cbb3 at 200 l
concentrations added as indicated. Experimental conditions as in Fig. 1.
Fig. 3. Inhibition of O2-reduction activity in the R. sphaeroides aa3 and cbb3 HCuOs as a fun
lines) to Eq. (1) to yield IC50 (see Section 2) of 60 nM NO for aa3 (A, green line) and 280 n
conditions as in Fig. 1.
Fig. 4. NO inhibition in R. sphaeroides cbb3 compared to Vibrio cholerae cbb3 at 200 (A) an
for Vc cbb3 in A (280 nM NO for Rs cbb3) and 6 nM NO for Vc cbb3 in B (60 nM NO for Rsobtained IC50s are only approximate. For the mitochondrial oxidase
(in brain synaptosomes) 50% inhibition (IC50) occurs at 270 nM NO
at O2 = 145 lM and at 60 nM NO when O2 is 30 lM [14]. These are
higher values than we obtain for the R. sphaeroides aa3, (60 nM NO
at 200 lM O2 and 6 nM NO at 60 lM O2); however, in brain synap-
tosomes the concentration of the oxidase was not known, so the
values cannot be directly compared.
A more detailed analysis of the Ki for the competitive inhibitor
NO would involve determining the apparent KM for O2 at varying
NO concentrations, as done for rat liver mitochondria [26] where
a Ki for NO of 27 nM was reported. We note also that since the
KM for O2 is lower for cbb3 (7 nM in the cbb3 from Bradyrhizobium
japonicum [7]), than for the A-type oxidases (50–150 nM [7,27])M (A) and 60 lM (B) O2. O2-consumption is initiated as in Fig. 1 and different NO
ction of added [NO] at 200 lM (A) and 60 lMO2 (B). Data obtained was ﬁtted (solid
M NO for cbb3 in A and 6 nM NO for aa3 and 60 nM NO for cbb3 in B. Experimental
d 60 (B) lM O2. Fitting the data obtained as described gives apparent IC50s of 30 nM
cbb3). Experimental conditions as in Fig. 1.
1218 D. Arjona et al. / FEBS Letters 589 (2015) 1214–1218the IC50 values for a competitive inhibitor should increase if the
true Ki is the same. By this, the C-type oxidases could be said to
have a kind of protection against NO inhibition simply by having
a low KM for O2, but although low, the exact KM value for O2 might
also vary between cbb3s from different species, which would itself
result in differences in the observed IC50s for NO.
For the mitochondrial aa3 oxidase, however, NO does not act
only as a competitive inhibitor, as it can bind also to the oxidized
state as well as to several O2 intermediates. NO can also be oxi-
dized by the oxidized, as well as the intermediate P and F states
producing nitrite-bound oxidase [13]. Furthermore, the mitochon-
drial aa3 can even produce NO, i.e. act as a nitrite reductase, when
the concentration of O2 is low [28]. This is possibly related to the
difference we observe in the inhibition pattern by nitrite between
R. sphaeroides aa3 and cbb3 (see Section 3).
In summary, cbb3-type oxidases do, as the aa3-type, show
strong inhibition by NO. There are mechanistic differences in the
details of NO inhibition between different heme-copper oxidases
and future studies of these details should further elucidate not only
this physiologically important interaction, but also the differences
in catalytic site dynamics between the different members of the
HCuO superfamily.
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